Treatment of depression in people who have multiple sclerosis

Abstract

Depression is common among people with multiple sclerosis (MS). Research suggests that treatments for depression are effective in this population, though few patients appear to access these treatments. Our objectives were to consider whether persons with MS and significant depressive symptoms, prompted to seek treatment by letter, did so, what professionals they consulted, and the benefits of any treatment obtained. A total of 495 individuals with MS (401 female; 94 male), aged 22-65 years (mean: 45.8 years), were surveyed in three phases at yearly intervals. Significant depressive symptoms were found over the three phases (50-60.2%). Despite a high prevalence of depressive symptoms, few participants sought treatment, even though prompted to do so. Where treatment was sought, general practitioners remained the principal group consulted. Contrary to previous reports of the efficacy of treatment in clinical trials, no strong support for this was found. Future research needs to consider why the majority of people with MS do not seek treatment for depression, and why interventions, which are not clinical trials, seem to lack effectiveness. Multiple Sclerosis 2007; 13: 632-635. http://msj.sagepub.com

Keywords

depression health services accessibility multiple sclerosis treatment outcome

Get full access to this article

View all access options for this article.

References

Schubert Dsp , Foliart RH Increased depression in multiple sclerosis: a meta-analysis. Psychosomatics 1993; 34: 124-30.

Feinstein A . Multiple sclerosis, depression and suicide: clinicians should pay more attention to psychopathology. BMJ 1997; 315: 691-92.

Sadovnick Ad , Remick RA , Allen J. , Swartz E. , Yee Iml , Eisen K. et al. Depression and multiple sclerosis. Neurology 1996; 46: 628-32.

Minden SL , Orav J. , Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987; 9: 426-34.

Thomas PW , Thomas S. , Hillier C. , Galvin K. , Baker R. Psychological interventions flor multiple sclerosis (protocol flor a Cochrane Review). The Cochrane Library, Issue 3. John Wiley & Sons Ltd, 2004.

Mohr DC , Goodkin DE , Likosky W. , Gatto N. , Baumann KA , Rudick RA Treatment ofl depression improves adherence to interfleron beta-1b therapy flor multiple sclerosis. Arch Neurol 1997; 54: 531-33.

Mohr DC , Neilly L. , Gatto N. , Goodkin DE Depression, coping and level ofl neurological impairment in multiple sclerosis . Mult Scler 1997; 3: 254-58.

Mohr DC , Goodkin DE Treatment ofl depression in multiple sclerosis: review and meta-analysis . Clin Psychol: Sci Pract 1999; 6: 1-9.

Mohr DC , Boudewyn AC , Goodkin DE , Bostrom A. , Epstein L. Comparative outcomes flor individual cognitive-behaviour therapy, supportive expressive group therapy, and sertraline flor the treatment ofl depression in multiple sclerosis. J Consult Clin Psychol 2001; 69: 942-49.

10.

National Institute for Clinical Excellence. Multiple sclerosis: national clinical guideline for diagnosis and management in primary and secondary care. Royal College ofl Physicians , 2004.

11.

Feinstein A. The neuropsychiatry ofl multiple sclerosis . Can JPsychiatry 2004; 49: 157-63.

12.

Minden SL Mood disorders in multiple sclerosis: diagnosis and treatment. J NeuroVirol 2000; 6: S160-67.

13.

Schiffer RB , Wineman NM Antidepressant pharmacotherapy ofl depression associated with multiple sclerosis. Am JPsychiatry 1990; 147: 1493-97.

14.

Clinical Standards Advisory Group.

Services for people with depression. Department ofl

Health , 2000.

15.

Feinstein A. An examination ofl suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674-78.

16.

Radloff LS The CES-D scale: a selfl-report depression scale flor research in the general population. Appl Psychol Measure 1977; 3: 385-401.

17.

Kneebone II , Dunmore E. Attributional style and symptoms ofl depression in persons with multiple sclerosis. Int J Behav Med 2004; 11: 110-15.

18.

Jorm AF Does old age reduce the risk ofl anxiety and depression? A review ofl epidemiological studies across the adult lifle span. Psychol Med 2000; 30: 11-22.

19.

Kneebone II , Dunmore E. , Evans E. Symptoms ofl depression in older adults with multiple sclerosis (MS): comparison with a matched sample ofl younger adults . AgingMentHealth 2003; 7: 182-85.

20.

Millard RW The Functional Assessment Screening Questionnaire: application flor evaluating pain related disability. Arch Phys Med Rehabil 1989; 70: 303-307.

21.

Verdier-Taillefer MH , Gourlet V. , Fuhrer R. , Alperovitch A. Psychometric properties ofl the Centre flor Epidemiologic Studies - Depression Scale in multiple sclerosis. Neuroepidemiology 2001 ; 20: 262-67.

22.

Johnston M. , Wright S. , Weinman J. Measures in health psychology: a users portfolio . Nfler-Nelson, 1995.

23.

Bristow K. , Patten S. Treatment seeking rates and associated mediating flactors among individuals with depression. Can J Psychiatry 2002; 47: 660-65.

24.

MacDonald BK , Cockerell OC, Sander JWAS, Shorvon SD. The incidence and lifletime prevalence ofl neurological disorders in a prospective community-based study in the UK. Brain 2000; 123: 665-76.